Evotec Se Adr Stock Today
| EVO Stock | USD 7.65 0.29 3.94% |
Performance0 of 100
| Odds Of DistressLess than 12
|
Evotec SE is selling at 7.65 as of the 23rd of April 2024; that is 3.94% increase since the beginning of the trading day. The stock's open price was 7.36. Evotec SE has less than a 12 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Equity ratings for Evotec SE ADR are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 24th of March 2024 and ending today, the 23rd of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 4th of December 2009 | Category Healthcare | Classification Health Care |
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany. Evotec Se operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. The company has 354.37 M outstanding shares of which 74.42 K shares are currently shorted by investors with about 1.26 days to cover. More on Evotec SE ADR
Moving against Evotec Stock
| 0.6 | PBH | Prestige Brand Holdings Financial Report 2nd of May 2024 | PairCorr |
| 0.51 | RDY | Dr Reddys Laboratories Financial Report 8th of May 2024 | PairCorr |
| 0.51 | CNTA | Centessa Pharmaceuticals Downward Rally | PairCorr |
| 0.5 | MRUS | Merus BV Financial Report 2nd of May 2024 | PairCorr |
| 0.49 | LRMR | Larimar Therapeutics Financial Report 20th of May 2024 | PairCorr |
| 0.46 | PAHC | Phibro Animal Health Financial Report 1st of May 2024 | PairCorr |
| 0.45 | ANIP | ANI Pharmaceuticals Financial Report 13th of May 2024 | PairCorr |
Evotec Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Evotec SE's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Evotec SE or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Mark Finlay | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, OMXS 30 Index, OMX Nordic 40, OMXS BENCH GI, OMX Stockholm Large, OMX Stockholm, OMX Stockholm 30, Health Care, Biotechnology, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Evotec SE report their recommendations after researching Evotec SE's financial statements, talking to executives and customers, or listening in on Evotec SE's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Evotec SE ADR. The Evotec consensus assessment is calculated by taking the average forecast from all of the analysts covering Evotec SE. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the measurements of operating efficiency obtained from Evotec SE's historical financial statements, Evotec SE ADR is not in a good financial situation at this time. It has a very high odds of going through financial crisis in May. Financial strength of Evotec SE ADR is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Evotec SE's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Evotec SE's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Evotec SE's financial leverage. It provides some insight into what part of Evotec SE's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Evotec SE ADR (EVO) is traded on NASDAQ Exchange in USA. It is located in Essener Bogen 7, Hamburg, Germany, 22419 and employs 5,086 people. Evotec SE is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a total capitalization of 2.61 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Evotec SE's market, we take the total number of its shares issued and multiply it by Evotec SE's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Evotec SE ADR runs under Biotechnology sector within Health Care industry. The entity has 354.37 M outstanding shares of which 74.42 K shares are currently shorted by investors with about 1.26 days to cover.
Evotec SE ADR has about 823.67 M in cash with (18.34 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.33.
Check Evotec SE Probability Of Bankruptcy
Ownership AllocationEvotec SE ADR retains a total of 354.37 Million outstanding shares. Roughly 98.0 percent of Evotec SE outstanding shares are held by general public with 1.6 % by other corporate entities. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Evotec Ownership Details
Evotec Stock Price Odds Analysis
Contingent on a normal probability distribution, the odds of Evotec SE jumping above the current price in 90 days from now is about 28.69%. The Evotec SE ADR probability density function shows the probability of Evotec SE stock to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon the stock has a beta coefficient of 1.7777 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Evotec SE will likely underperform. Additionally, evotec SE ADR has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Evotec SE to move above the current price in 90 days from now is about 28.69 (This Evotec SE ADR probability density function shows the probability of Evotec Stock to fall within a particular range of prices over 90 days) .
Evotec Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Evotec SE that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Evotec SE's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Evotec SE's value.| Instituion | Recorded On | Shares | |
| Bank Of America Corp | 2023-12-31 | 5.7 K | |
| Fmr Inc | 2023-12-31 | 3 K | |
| Ubs Group Ag | 2023-12-31 | 2.3 K | |
| Quadrant Capital Group Llc | 2023-12-31 | 2.1 K | |
| U.s. Bancorp | 2023-12-31 | 1.2 K | |
| Signaturefd, Llc | 2023-12-31 | 994 | |
| Hhm Wealth Advisors, Llc | 2023-12-31 | 450 | |
| Gamma Investing Llc | 2023-12-31 | 285 | |
| First Manhattan Co. Llc | 2023-12-31 | 225 | |
| Mubadala Investment Company Pjsc | 2023-12-31 | 4.6 M | |
| Federated Hermes Inc | 2023-12-31 | 576.9 K |
Evotec SE Historical Income Statement
Evotec SE ADR Income Statement is one of the three primary financial statements used for reporting Evotec's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Evotec SE ADR revenue and expense. Evotec SE Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Evotec SE's Gross Profit is very stable compared to the past year. As of the 23rd of April 2024, Interest Expense is likely to grow to about 11.4 M, though EBITDA is likely to grow to (19.4 M). View More FundamentalsEvotec Stock Against Markets
Picking the right benchmark for Evotec SE stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Evotec SE stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Evotec SE is critical whether you are bullish or bearish towards Evotec SE ADR at a given time. Please also check how Evotec SE's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Evotec SE without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Commodity Directory Now
Commodity DirectoryFind actively traded commodities issued by global exchanges |
| All Next | Launch Module |
Evotec SE Corporate Directors
Evotec SE corporate directors refer to members of an Evotec SE board of directors. The board of directors generally takes responsibility for the Evotec SE's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Evotec SE's board members must vote for the resolution. The Evotec SE board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Anthony Quirk | Non-Independent Non-Executive Director | Profile | |
| Norah Barlow | Independent Director | Profile | |
| Grainne Troute | Independent Non-Executive Director | Profile | |
| Hamish Stevens | Independent Director | Profile |
How to buy Evotec Stock?
Before investing in Evotec SE, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Evotec SE. To buy Evotec SE stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Evotec SE. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Evotec SE stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Evotec SE ADR stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Evotec SE ADR stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Evotec SE ADR, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Evotec Stock please use our How to Invest in Evotec SE guide.
Already Invested in Evotec SE ADR?
The danger of trading Evotec SE ADR is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Evotec SE is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Evotec SE. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Evotec SE ADR is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Evotec SE ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Evotec SE's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Evotec Se Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Evotec Se Adr Stock: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evotec SE ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Complementary Tools for Evotec Stock analysis
When running Evotec SE's price analysis, check to measure Evotec SE's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evotec SE is operating at the current time. Most of Evotec SE's value examination focuses on studying past and present price action to predict the probability of Evotec SE's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evotec SE's price. Additionally, you may evaluate how the addition of Evotec SE to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |
Is Evotec SE's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evotec SE. If investors know Evotec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evotec SE listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.28) | Revenue Per Share 2.321 | Quarterly Revenue Growth 0.129 | Return On Assets 0.0017 | Return On Equity (0.08) |
The market value of Evotec SE ADR is measured differently than its book value, which is the value of Evotec that is recorded on the company's balance sheet. Investors also form their own opinion of Evotec SE's value that differs from its market value or its book value, called intrinsic value, which is Evotec SE's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evotec SE's market value can be influenced by many factors that don't directly affect Evotec SE's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evotec SE's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evotec SE is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evotec SE's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.